GENERAL APPLICABILITY OF A NEW TREAT-TO-TARGET TREATMENT STRATEGY IN DUTCH PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: RESULTS FROM THE DREAM REMISSION INDUCTION COHORT II

被引：0
|
作者：
Steunebrink, L. M. M. [1 ]
Vonkeman, H. E. [1 ]
Ten Klooster, P. M. [2 ]
Kuper, H. H. [1 ]
van der Bijl, A. E. [3 ]
van Riel, P. L.
van de Laar, M. A. [1 ]
机构：
[1] Med Spectrum Twente, Rheumatol, Enschede, Netherlands
[2] Univ Twente, Psychol Hlth & Technol, Enschede, Netherlands
[3] Isala Klin, Rheumatol, Zwolle, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4437
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0118
引用
收藏
页码：237 / 237
页数：1
相关论文
共 50 条
  • [31] Distinct Trajectories of Disease Activity Over the First Year in Early Rheumatoid Arthritis Patients Following a Treat-to-Target Strategy
    Siemons, Liseth
    ten Klooster, Peter M.
    Vonkeman, Harald E.
    Glas, Cees A. W.
    van de Laar, Mart A. F. J.
    [J]. ARTHRITIS CARE & RESEARCH, 2014, 66 (04) : 625 - 630
  • [32] TREAT-TO-TARGET STRATEGY OF >8.000 PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: DOES SMOKING AFFECT ACHIEVEMENT OF REMISSION ON METHOTREXATE AND TIME TO START OF FIRST BIOLOGIC? RESULTS FROM THE NATIONWIDE DANISH DANBIO REGISTRY
    Glintborg, B.
    Hendricks, O.
    Colic, A.
    Lindegaard, H. M.
    Ahmed, R.
    Loft, A. G.
    Kollerup, G.
    Andersen, M.
    Grydehoj, J.
    Raun, J.
    Thorgrimsen, T.
    Mortensen, K.
    Uhrenholt, L.
    Jensen, D.
    Ruge, I.
    Kalisz, M.
    Danebod, K.
    Lomborg, N.
    Krogh, N. Steen
    Hetland, M. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 997 - 998
  • [33] Monitoring Patients with Rheumatoid Arthritis in Routine Care Experiences from a Treat-to-Target Strategy Using the Danbio Registry
    Hetland, Merete Lund
    Jensen, Dorte Vendelbo
    Krogh, Niels Steen
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S804 - S804
  • [34] Monitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry
    Hetland, M. L.
    Jensen, D. V.
    Krogh, N. S.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : S141 - S146
  • [35] Association between Disease Activity and Radiographic Progression in the Current Treat-to-Target Paradigm of Rheumatoid Arthritis: Real World Data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) Registry
    ten Klooster, Peter M.
    Steunebrink, Laura M. M.
    Versteeg, Letty
    de la Torre, Inmaculada
    de Leonardis, Francesco
    Fakhouri, Walid
    Zaremba-Pechmann, Liliana
    van de Laar, Mart
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [36] Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort
    Sepriano, Alexandre
    Ramiro, Sofia
    Landewe, Robert
    van der Heijde, Desiree
    Ohrndorf, Sarah
    FitzGerald, Olivier
    Backhaus, Marina
    Larche, Maggie
    Homik, Joanne
    Saraux, Alain
    Hammer, Hilde B.
    Terslev, Lene
    Ostergaard, Mikkel
    Burmester, Gerd
    Combe, Bernard
    Dougados, Maxime
    Hitchon, Carol
    Boire, Gilles
    Lambert, Robert G.
    Dadashova, Rana
    Paschke, Joel
    Hutchings, Edna J.
    Maksymowych, Walter P.
    [J]. CLINICAL RHEUMATOLOGY, 2024, 43 (06) : 1833 - 1844
  • [37] Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patients
    Thomas, Konstantinos
    Lazarini, Argiro
    Kaltsonoudis, Evripidis
    Drosos, Alexandros
    Papalopoulos, Ioannis
    Sidiropoulos, Prodromos
    Tsatsani, Panagiota
    Gazi, Sousana
    Pantazi, Lina
    Boki, Kyriaki A.
    Katsimbri, Pelagia
    Boumpas, Dimitrios
    Fragkiadaki, Kalliopi
    Tektonidou, Maria
    Sfikakis, Petros P.
    Karagianni, Konstantina
    Sakkas, Lazaros I.
    Grika, Eleftheria P.
    Vlachoyiannopoulos, Panagiotis G.
    Evangelatos, Gerasimos
    Iliopoulos, Alexios
    Dimitroulas, Theodoros
    Garyfallos, Alexandros
    Melissaropoulos, Konstantinos
    Georgiou, Panagiotis
    Areti, Maria
    Georganas, Constantinos
    Vounotrypidis, Periklis
    Kitas, George D.
    Vassilopoulos, Dimitrios
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12
  • [38] PREDICTORS OF OUTCOME AT 1-YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE UK TREAT-TO-TARGET AUDIT
    Tan, Ai Lyn
    Buch, Maya
    O'Reilly, David
    Sheeran, Tom
    Keidel, Sarah
    Chitale, Sarang
    Emery, Paul
    [J]. RHEUMATOLOGY, 2016, 55 : 96 - 96
  • [39] COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF TREAT-TO-TARGET VERSUS USUAL CARE IN EARLY RHEUMATOID ARTHRITIS: RESULTS OF THE DREAM REGISTRY
    Vermeer, M.
    Kievit, W.
    Kuper, I.
    Braakman-Jansen, A.
    Moens, H. Bernelot
    Zijlstra, T.
    den Broeder, A.
    van Riel, P.
    Fransen, J.
    van de Laar, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 92 - 92
  • [40] Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis
    Yu, Chen
    Jin, Shangyi
    Wang, Yanhong
    Jiang, Nan
    Wu, Chanyuan
    Wang, Qian
    Tian, Xinping
    Li, Mengtao
    Zeng, Xiaofeng
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (03) : 727 - 738
12345